Rates of long-term treatment discontinuation were low among patients with ankylosing spondylitis receiving first-line anti-TNF therapy for at least 2 years.
The global ankylosing spondylitis treatment market is witnessing significant growth, with projections indicating a market value of USD 8.06 billion in 2022 and an expected increase to USD 5.1409 ...
Alongside medication and physical therapy for ankylosing spondylitis (AS), self-care plays a key role in managing symptoms and boosting your quality of life. Any activity that helps you feel ...
Ankylosing spondylitis (AS) is a type of inflammatory arthritis. It is chronic, which means it is a long-term condition. It usually affects the spine, but it may also affect tendons, ligaments, vital ...
For example, you and your doctor might consider surgery if your pain level gets to the point where you need excessive amounts of pain medications, says Aly Cohen, MD, an integrative ...
Background: Observational studies have shown an increased risk of ocular inflammatory diseases in patients with ankylosing spondylitis (AS), but the genetically predicted association remains unclear.
The Ankylosing Spondylitis (Bekhterev’s Disease) drugs in development market research report provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis ...